Weiske, Joerg
Nuvisan (Germany) · Bayer (Germany)
2 papers on CoChat
Most cited papers
- Verified
Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS–SOS1 interaction
Hillig, R. C., Sautier, B., Schroeder, J., Moosmayer, D., Hilpmann, A., Stegmann, C. M., Werbeck, N. D., Briem, H., Boemer, U., Weiske, J., et al. (2019) · Proceedings of the National Academy of Sciences
Protein Kinase Regulation and GTPase SignalingProtein Tyrosine Phosphatases
Cited by 388
- Verified
Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer
Dieter, S. M., Siegl, C., Codó, P. L., Huerta, M., Ostermann-Parucha, A. L., Schulz, E., Zowada, M. K., Martin, S., Laaber, K., Nowrouzi, A., et al. (2021) · Cell Reports
Protein Degradation and InhibitorsColorectal Cancer Treatments and Studies
Cited by 95
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free